González-Hernández Luz A, Alvarez-Zavala Monserrat, Cabrera-Silva Rodolfo I, Martínez-Ayala Pedro, Amador-Lara Fernando, Ramírez-González Aída S, Ron-Magaña Ana L, Ruiz Herrera Vida V, Sánchez-Reyes Karina, Andrade-Villanueva Jaime F
HIV Unit, Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco, Mexico.
HIV and Immunodeficiencies Research Institute, CUCS-University of Guadalajara, Guadalajara, Jalisco, Mexico.
AIDS Res Ther. 2020 Aug 14;17(1):52. doi: 10.1186/s12981-020-00304-0.
Hemophagocytic lymphohistiocytosis syndrome (HLS) is an immune-mediated life-threatening disease considered as a medical emergency, with a potentially fatal multisystem inflammatory outcome. We present a patient that developed HLS and was able to be diagnosed efficiently with the help of an academic research institute of immunology.
A 21 years old male Mexican with human immunodeficiency virus (HIV), late presenter; who developed cytomegalovirus (CMV) infection and a disseminated histoplasmosis-related HLS, as part of an immune reconstitution inflammatory syndrome (IRIS). The patient required a long course of corticotherapy, intravenous immunoglobulin and massive transfusions (more than 10 units in 24 h, and a total of 83 units), besides amphotericin-B and ganciclovir treatment. An academic research institute of immunology aided in the accurate diagnosis of HLS with the implementation of tests not available within the hospital, thus improving the care provided to the patient. The patient recovered, was discharged, and continue to improve.
The objective of this report is to highlight the importance of having multidisciplinary support, including basic medical sciences groups providing specific tests that are sometimes very difficult to get, which provides a benefit to patients in the well-aimed diagnosis as part of applied translational medicine.
噬血细胞性淋巴组织细胞增生症综合征(HLS)是一种免疫介导的危及生命的疾病,被视为医疗急症,具有潜在致命的多系统炎症后果。我们报告一名发生HLS的患者,在一家免疫学术研究机构的帮助下得以有效诊断。
一名21岁的墨西哥男性,患有人类免疫缺陷病毒(HIV),就诊较晚;其发生了巨细胞病毒(CMV)感染及与播散性组织胞浆菌病相关的HLS,这是免疫重建炎症综合征(IRIS)的一部分。该患者除接受两性霉素B和更昔洛韦治疗外,还需要长期进行皮质激素治疗、静脉注射免疫球蛋白及大量输血(24小时内超过10单位,总共83单位)。一家免疫学术研究机构通过开展医院无法进行的检测,帮助准确诊断HLS,从而改善了对该患者的治疗。患者康复出院,并持续好转。
本报告的目的是强调多学科支持的重要性,包括基础医学团队提供有时很难获得的特定检测,这有助于患者进行精准诊断,是应用转化医学的一部分。